Emerging infectious diseases on the rise: Next target 'hotspot' predicted

It’s not just your imagination. Providing the first-ever definitive proof, a team of scientists has shown that emerging infectious diseases such as HIV, Severe Acute Respiratory Syndrome (SARS), West Nile virus and Ebola are indeed on the rise. The team – including University of Georgia professor John Gittleman and scientists from the Consortium for Conservation Medicine, the Institute of Zoology (London) and Columbia University – recently published their findings in leading scientific journal Nature.

By analyzing 335 incidents of previous disease emergence beginning in 1940, the study has determined that zoonoses – diseases that originate in animals – are the current and most important threat in causing new diseases to emerge. And most of these, including SARS and the Ebola virus, originated in wildlife. Antibiotic drug resistance has been cited as another culprit, leading to diseases such as extremely drug-resistant tuberculosis (XDR TB).

The scientists also found that more new diseases emerged in the 1980s than any other decade, “likely due to the HIV/AIDS pandemic, which led to a range of other new diseases in people,” said Mark Levy, deputy director of the Center for International Earth Science Information Network (CIESN) at Columbia University.

But this team did not stop with determining the causes and origins of emerging infectious diseases; they took it a step further. To help predict and prevent future attacks, sophisticated computer models were used to help design a global map of emerging disease hotspots.

“This is a seminal moment in how we study emerging diseases,” said Gittleman, dean of the Odum School of Ecology, who developed the approach used in analyzing the global database. “Our study has shown that bringing ecological sciences and public health together can advance the field in a dramatic way.”

Over the last three decades, billions of research dollars were unsuccessfully spent to try to explain the seemingly random patterns of infectious disease emergence and spread. Finally, this research gives the first insight about where future outbreaks may occur – and next up is likely the Tropics, a region rich in wildlife species and under increasing human pressure.

“Emerging disease hotspots are more common in areas rich in wildlife, so protecting these regions from development may have added value in preventing future disease emergence,” said Kate Jones, Senior Research Fellow of the Institute of Zoology.

Emerging diseases have caused devastating effects internationally, with millions infected and billions spent. Some diseases have become pandemic, spreading from one continent to another causing massive mortality rates and affecting global economies and livelihoods.

“This work by John and his collaborators is absolutely first rate, as evidenced by its publication in one of the world’s foremost scientific journals,” said UGA Vice President for Research David Lee. “It brings novel insights and perspective to the fight against global diseases and illustrates the tremendous potential of this new field of disease ecology. It is vital that we better understand how environmental factors, including man’s activities, affect the spread of infectious diseases.”

But knowing where the next outbreak is and understanding the reason for its occurrence does not alleviate the entire issue.

“The problem is, most of our resources are focused on the richer countries in the North that can afford surveillance – this is basically a misallocation of global health funding and our priority should be to set up ‘smart surveillance’ measures in these hotspots, most of which are in developing countries,” said Peter Daszak, executive director of the Consortium for Conservation Medicine. “If we continue to ignore this important preventative measure then human populations will continue to be at risk from pandemic diseases.”

Source: University of Georgia

Related stories:

'Nutraceuticals' could prevent diabetes
People at high risk for developing type 2 diabetes might be able to delay or prevent the disease by taking certain food supplements and making lifestyle changes, according to a new book by Dr. James W. Anderson, an internationally recognized authority on metabolic diseases and weight loss and professor emeritus of medicine and clinical nutrition at the University of Kentucky College of Medicine.
Carnegie Mellon MRI technology that non-invasively locates, quantifies specific cells in the body
Magnetic resonance imaging (MRI) isn't just for capturing detailed images of the body's anatomy. Thanks to novel imaging reagents and technology developed by Carnegie Mellon University scientist Eric Ahrens, MRI can be used to visualize — with "exquisite" specificity — cell populations of interest in the living body. The ability to non-invasively locate and track cells, such as immune cells, will greatly aid the study and treatment of cancer, inflammation, and autoimmune diseases, as well as provide a tool for advancing clinical translation of the emerging field of cellular regenerative medicine, by tracking stem cells for example.
First detection of 'odor profile' for skin cancer may lead to rapid, non-invasive diagnostic test
Chemists today described the first identification of a specific "odor profile" for skin cancer, a discovery that could form the basis of a rapid, non-invasive test for diagnosing the most common type of cancer in the United States. The findings may enable doctors in the future to diagnose skin cancer quickly and accurately by waving a handheld scanner or sensor above the skin, they reported today at the 236th national meeting of the American Chemical Society.
Shape, not just size, impacts effectiveness of emerging nanomedicine therapies
In the budding field of nanotechnology, scientists already know that size does matter. But now, researchers at the University of North Carolina at Chapel Hill have shown that shape matters even more — a finding that could lead to new and more effective methods for treating cancer and other diseases, from diabetes and multiple sclerosis to arthritis and obesity.
Data mining detects signs of Lou Gehrig's disease in gene carriers long before symptoms appear
Inspired by the use of microarray chips that look for gene combinations, psychologists are using "pattern array" software to spot movements in rats that might help them predict diseases such as Lou Gehrig's syndrome.
Simian foamy virus found in several people living and working with monkeys in Asia
A research team led by University of Washington scientists has found that several people in South and Southeast Asian countries working and living around monkeys have been infected with simian foamy virus (SFV), a primate virus that, to date, has not been shown to cause human disease. The findings provide more evidence that Asia, where interaction between people and monkeys is common and widespread, could be an important setting for future primate-to-human viral transmission. The study appears in the August issue of the journal Emerging Infectious Disease.
String probes for devastating childhood digestive disease
A swallowed string may someday replace the invasive, uncomfortable endoscope now used to diagnose eosinophilic esophagitis, a devastating childhood disease of the esophagus.
Statins may protect against memory loss
People at high risk for dementia who took cholesterol-lowering statins are half as likely to develop dementia as those who do not take statins, a new study shows.

News discussion:

Medicine & Health news